Date(s)

18 Sep 2024

Location

Liverpool, United Kingdom

Meeting type

Hybrid Meeting

CME Credits: 1.5 points

The Liverpool Course 2024

Related Enduring Materials

Enduring Materials

DDI Management in HIV Care: The Liverpool Course 2024 -

LA Beyond HIV

Andrew Owen, BSS, MSC, PhD, FSB

University of Liverpool, United Kingdom

Case 1: Gender Transitioning with ARVs

Tessa Senneker, PharmD

Kingston Health Sciences Centre, Canada

Video

Slideset

Case 2: Substituting Statins – Same or Different?

Thomas Heseltine, MBChB(Hons), MRCP, PhD

Liverpool University Hospitals Trust, University of Liverpool, United Kingdom

Video

Slideset

Dolutegravir with TB Treatment, How Low is Too Low?

Geraint Rhys Davies, BM, PhD, FRCP, DTM&H

Liverpool University Hospitals Foundation Trust / University of Liverpool, United Kingdom

Video

Slideset

Q&A Session

Saye Khoo, MD, PhD

Royal Liverpool University Hospital; University of Liverpool, United Kingdom

Catia Marzolini, PharmD, PhD

University Hospital of Basel, University Hospital of Lausanne, Switzerland; University of Liverpool, United Kingdom

Andrew Owen, BSS, MSC, PhD, FSB

University of Liverpool, United Kingdom

Tessa Senneker, PharmD

Kingston Health Sciences Centre, Canada

Thomas Heseltine, MBChB(Hons), MRCP, PhD

Liverpool University Hospitals Trust, University of Liverpool, United Kingdom

Geraint Rhys Davies, BM, PhD, FRCP, DTM&H

Liverpool University Hospitals Foundation Trust / University of Liverpool, United Kingdom

Overview

About this Program

The 6th edition of the DDI Management in HIV Care: The Liverpool Course 2024 took place on 18 September 2024.

Designed and developed by renowned experts in the field of HIV care and pharmacology, The Liverpool Course aims to educate participants on key concepts in clinical pharmacology and drug-drug interactions that remain a major consideration in the management of people living with HIV.

The course is organized in collaboration with the University of Liverpool and the leading experts who developed the Liverpool HIV drug interactions checker - a comprehensive drug-drug-interaction resource freely available to healthcare practitioners worldwide.

Program Chairs 2024

Saye Khoo, MD, PhD

Royal Liverpool University Hospital; University of Liverpool, United Kingdom

Fiona Marra, FRPharmS

University of Liverpool, United Kingdom

Catia Marzolini, PharmD, PhD

University Hospital of Basel, University Hospital of Lausanne, Switzerland; University of Liverpool, United Kingdom

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVP

Toronto General Hospital, University of Toronto, Canada

General Information

Who Should Attend?

- Primary: Healthcare professionals involved in the management and treatment of people living with HIV.

- Secondary: ID physicians, pharmacists, specialist nurses.

- Tertiary: Researchers.

Meeting Objectives

This meeting aims to:

- Reinforce and develop the understanding of key clinical pharmacology concepts among junior colleagues in the fields of infectious diseases and hepatology (clinicians, pharmacists, academics, industry colleagues etc.).

- Improve clinical pharmacology education and thereby the quality of patient care.

- Educate healthcare professionals on how to use the Liverpool Drug Interaction Resources in their clinical practice.

- Increase knowledge and confidence among healthcare professionals through practical examples of the Liverpool Drug Interactions Resources and discussion of case studies tailored to the local needs.

Learning Objectives

After participating in this activity, participants will be able to:

- Describe in detail the terms pharmacodynamics and pharmacokinetics.

- Define what is meant by clinically significant DDI and discuss DDI mechanisms.

- Use the Liverpool DDI Resource with confidence in their daily practice.

- Identify the potential of DDIs of ARVs and DAAs and use this information to improve their decision making in daily practice.

Practical Information

Venue

Address:
Spaces at The Spine
The Spine Building, 2 Paddington Village,
Liverpool L7 3FA,
United Kingdom

Distance from Manchester Airport (MAN): 50 minutes

Accommodation

Accommodation is not included in the registration fee.

You are welcome to book a room at the conference venue at a reduce rate during registration.

Regular room rate (incl. VAT):
Double room rate (incl. VAT):

Please contact EMAIL with questions or refer to the FAQ.

Certificate of Attendance

A certificate of attendance will be sent to participants who successfully completed the program and post-meeting survey.

Language

The official language of the meeting is English.

Disclaimer

This course is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this course. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the course.

Liability and Insurance

By registering for the course, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the course is finished, provided the speaker has given permission to do so.

Code of Conduct

All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.

Accreditation

EACCME® Accreditation Statement

The Liverpool Course 2024, Liverpool, United Kingdom, 18/09/2024 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities occurring outside of Canada, recognized by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Support